Search Orphan Drug Designations and Approvals
-
Generic Name: | met-enkephalin; Met-N |
---|---|
Date Designated: | 02/18/2011 |
Orphan Designation: | Treatment of pancreatic cancer. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
NBI Pharmaceuticals, Inc. 1087 Stoneridge Drive Bozeman, Montana 59718 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-